Regional Speakers

A/Prof Benita Tan is a Senior Consultant Breast Surgeon in the Department of General Surgery in Sengkang General Hospital, and the current Chairman of the Division of Surgery at Sengkang General Hospital.

Dr Yip is currently a consultant breast surgeon in Ramsay Sime Darby Health Care in Malaysia, and holds an appointment as Clinical Professor in the Faculty of Medicine, University Tunku Abdul Rahman, and Kuala Lumpur. She is also the lead clinician for the breast cancer research program in the Cancer Research Malaysia, which is a charity-based cancer research organization. She has been appointed an expert in cancer control by the World Health Organization and the International Atomic Energy Agency (IAEA), and has been on expert panels in international organizations such as the International Cancer Control Conference, and the Breast Health Global Initiative.

Dr Lim Wei Tching Faye Lynnette works at National Cancer Centre Singapore in the Division of Radiation Oncology as a Consultant BMedSci (Nottingham), MBBS (Nottingham), MRCP (UK), FRCR (Clinical Oncology)(UK). Her area of specialty is Radiation Oncology and sub-specialties are Breast, Hepato-Pancreato-Biliary, Upper Gastrointestinal, and Colorectal.

Dr Jack Chan is a Consultant Medical Oncologist who practises at National Cancer Centre Singapore and KK Women’s and Children’s Hospital, subspecialising in gynaecological and breast cancers. Dr Chan serves as Secretary of Gynecologic Cancer Group Singapore, and also sits on the Japanese Society of Medical Oncology’s International Steering Committee and Asian Society of Gynecologic Oncology’s Special Task Force on Personalized Medicine. Dr Chan’s research interests include early and late phase clinical trials and translational work in female cancers. He is the Principal Investigator of investigator-initiated and industry-sponsored trials.

Dr. Mabel Wong is a Senior Consultant in the Division of Medical Oncology at National Cancer Centre Singapore, and Visiting Consultant at KK Hospital. She obtained her undergraduate medical degree from the National University of Singapore. Dr. Mabel has been practicing in Singapore since 2008, focusing mainly on medical oncology. Her research interests include early phase clinical trials in breast and gynaecology oncology and neo-adjuvant therapy in breast cancer.

Dr. Mastura Md. Yusof is the Head of Oncology Services at Pantai Hospital Kuala Lumpur and a Consultant Clinical Oncologist at Subang Jaya Medical Centre, Malaysia. She leads the research unit at Pantai Hospital Kuala Lumpur, overseeing numerous clinical trials in breast, GI and lung cancer including fundamental trials that resulted in the approval of pembrolizumab in metastatic triple negative breast cancer. She is actively participating in international clinical trials in varied innovative therapies such as targeted therapies, PARP inhibitors, immunotherapies and antibody-drug conjugates and has co-authored numerous peer-reviewed publications in national and international journals.

Prof Roger Daniel Vaughan is the Director for the Centre for Quantitative Medicine (CQM) and Centre for Clinician Scientist Development (CCSD) and he is also the Associate Dean for the Office of Research at the Duke-NUS Medical School, Singapore. Prior to that, he was the Director of Biostatistics at The Rockefeller University Hospital, and Professor at the Weill Cornell Graduate School of Medical Sciences.

Dr Samuel Ow strongly believes in the importance of training the next generation of physicians. He is an Assistant Professor on the Clinician-Educator track at the Yong Loo Lin School of Medicine, and is currently the Associate Program Director of the Medical Oncology Senior Residency Program at NCIS.

.

Dr. Sung-Bae Kim is a Professor at Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. He attained his MD and PhD from Kyunghee University Medical School, completed clinical training in internal medicine at Ewha Womans University and undertook a clinical fellowship at Division of Hematology-Oncology at Asan Medical Center.

Dr Tira Tan is a consultant medical oncologist at the National Cancer Centre Singapore with a clinical focus in the treatment of breast cancers and early phase drug development. Dr Tan chairs the pre-operative and young women’s breast cancer programs at NCCS and is the divisional deputy director of research as well as a primary and co-investigator on many early and late phase studies specifically in novel therapeutics and treatment strategies in triple negative breast cancer.

Clinical Associate Professor Veronique Tan is a Senior Consultant and Chief of Breast Surgery at National Cancer Centre Singapore and Singapore General Hospital. She also Heads the SingHealth Duke-NUS Breast Centre. As one of the few breast surgeons in Singapore formally trained in oncoplastic breast surgery, A/Prof Tan believes that the appearance of the breast after cancer resection is important, and that every patient should have a tailored, individualised surgical solution. She works within a dynamic multidisciplinary team to deliver precise, high quality and effective treatment.

Dr Wong Nan Soon is an oncologist practising at Gleneagles Hospital and Mount Elizabeth Hospitals, Singapore. His subspecialty interests are in breast cancer and gastrointestinal cancer. He completed his advanced specialty training in general medical oncology in 2003, and subsequently a clinical fellowship subspecializing in breast medical oncology in Sunnybrook and Women’s Health Science Centre in Canada, where he trained under world-renowned breast oncologists including Professor Kathleen Pritchard. He was promoted to the position of consultant in 2006 and subsequently rose to the position of senior consultant and chief of the breast team in the department of medical oncology at National Cancer Centre, Singapore

Dr. Yap is Senior Consultant in the Division of Medical Oncology at the National Cancer Centre Singapore, and Associate Professor at Duke-National University Singapore. A recipient of the Singapore National Medical Research Council (NMRC) Clinician Scientist Award (CSA), her research focuses primarily on clinical and translational research in breast cancer, including liquid biopsies and predictive biomarkers, development of novel therapeutic strategies, and epidemiologic studies on treatment outcomes in breast cancer.